← The Wire
OTLKNasdaq
Outlook Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1649989
Develops and markets ONS-5010/LYTENAVA, an ophthalmic bevacizumab for wet AMD treatment
red 8-K · 90d
$181M
Market cap
$1.69
Last close
-1.2%
1D
-7.7%
5D
7.9M
Volume
Price · last 39 sessions+543.8%
May 4L $0.22 · H $1.83Jun 29
283
Total filings
Jun 26, 2026
Last filing
09/30
Fiscal year end
8-KDelisting NoticeJun 26, 20268-KCompany UpdateJun 16, 2026DEFA14ADEFA14AJun 1, 2026DEF 14ADEF 14AJun 1, 20268-KCompany UpdateJun 1, 2026SC 13D/ASC 13D/AJun 1, 20268-KCompany UpdateMay 29, 2026424B5424B5May 29, 20268-KCompany UpdateMay 28, 20268-KCompany UpdateMay 26, 20268-KResults of OperationsMay 18, 202610-Q10-QMay 15, 2026424B5424B5May 13, 20268-KMaterial Agreement · Agreement TerminatedMay 13, 20268-KEquity Issuance · Company UpdateApr 23, 2026424B5424B5Apr 23, 20268-KCompany UpdateApr 21, 20268-KCompany UpdateApr 7, 20268-KCompany UpdateMar 25, 2026424B5424B5Mar 25, 2026424B5424B5Mar 23, 20268-KMaterial Agreement · New Debt / ObligationMar 16, 20268-KExecutive ChangeMar 11, 20268-KShareholder VoteMar 10, 20268-KCompany UpdateMar 5, 20268-KDelisting NoticeFeb 18, 202610-Q10-QFeb 17, 20268-KResults of OperationsFeb 17, 20268-KCompany UpdateFeb 11, 2026DEFA14ADEFA14AJan 26, 2026DEF 14ADEF 14AJan 26, 20268-KCompany UpdateJan 2, 202610-K10-KDec 19, 20258-KResults of OperationsDec 19, 20258-KCompany UpdateNov 13, 20258-KCompany UpdateNov 3, 20258-KCompany UpdateSep 29, 20258-KExecutive ChangeSep 5, 20258-KCompany UpdateSep 2, 202510-Q10-QAug 14, 20258-KResults of OperationsAug 14, 20258-KExecutive ChangeJul 1, 20258-KCompany UpdateJun 2, 2025424B5424B5May 23, 20258-KCompany UpdateMay 23, 2025424B5424B5May 22, 20258-KResults of OperationsMay 15, 202510-Q10-QMay 15, 20258-KExecutive ChangeApr 11, 20258-KCompany UpdateApr 8, 20258-KAgreement Terminated · Bylaw AmendmentMar 14, 20258-KCompany UpdateFeb 28, 202510-Q10-QFeb 14, 20258-KResults of OperationsFeb 14, 2025DEF 14AFORM DEF 14AFeb 10, 20258-KExecutive Change · Material AgreementJan 31, 202510-K/A10-K/AJan 23, 20258-KMaterial Agreement · Equity IssuanceJan 16, 202510-K10-KDec 27, 20248-KResults of OperationsDec 27, 20248-KExit / Disposal CostsDec 16, 20248-KExecutive ChangeDec 4, 20248-KCompany UpdateNov 27, 202410-Q10-QAug 14, 20248-KResults of OperationsAug 14, 20248-KCompany UpdateJul 8, 2024DEF 14ADEF 14AJun 26, 20248-KCompany UpdateMay 28, 20248-KResults of OperationsMay 15, 202410-Q10-QMay 15, 20248-KCompany UpdateMay 13, 20248-KCompany UpdateMay 1, 20248-KEquity IssuanceApr 15, 2024424B5424B5Apr 12, 20248-KCompany UpdateApr 12, 2024SC 13GSC 13GApr 8, 20248-KCompany UpdateApr 2, 2024SC 13GTHE SCHEDULE 13GMar 28, 2024SC 13GSC 13GMar 28, 20248-KExecutive ChangeMar 26, 2024
Similar companies
Comparable business profile · signals at a glance